Search

Your search keyword '"Ole Lander Svendsen"' showing total 82 results

Search Constraints

Start Over You searched for: Author "Ole Lander Svendsen" Remove constraint Author: "Ole Lander Svendsen"
82 results on '"Ole Lander Svendsen"'

Search Results

1. Risk factors for development of nephropathy in patients with a diabetic Charcot foot

2. Long-Term Changes in Sarcopenia and Body Composition in Diabetes Patients with and without Charcot Osteoarthropathy

3. Study protocol for optimising glycaemic control in type 1 diabetes treated with multiple daily insulin injections: intermittently scanned continuous glucose monitoring, carbohydrate counting with automated bolus calculation, or both? A randomised controlled trial

4. Long-term effects on the progress of neuropathy after diabetic Charcot foot: an 8.5-year prospective case–control study

5. Healing of Diabetic Foot Ulcers in Patients Treated at the Copenhagen Wound Healing Center in 1999/2000 and in 2011/2012

6. Markers of Local Inflammation and Bone Resorption in the Acute Diabetic Charcot Foot

7. Flash glucose monitoring and automated bolus calculation in type 1 diabetes treated with multiple daily insulin injections: a 26 week randomised, controlled, multicentre trial

8. Quality of diabetes treatment in four orthopaedic departments in the Capital Region of Denmark

9. 150-OR: Intermittently Scanned Continuous Glucose Monitoring and Automated Bolus Calculation in Type 1 Diabetes Treated with Multiple Daily Insulin Injections: A Randomized Controlled Trial

10. Fractures and Osteoporosis in Patients With Diabetes With Charcot Foot

11. How Common Is the Rare Charcot Foot in Patients With Diabetes?

12. Risk Factors for Premature Death in Diabetes Patients who Undergo Amputations below Ankle Level

13. The Diabetic Foot in a Multidisciplinary Team Setting. Number of Amputations below Ankle Level and Mortality

14. Mortality and complications after treatment of acute diabetic Charcot foot

15. A review of bone metabolism and developments in medical treatment of the diabetic Charcot foot

16. Sarcopenia and body composition in diabetic Charcot osteoarthropathy

17. Bone Loss in Women with Type 1 Diabetes

18. Bone mineral density and markers of bone turnover and inflammation in diabetes patients with or without a Charcot foot: An 8.5-year prospective case-control study

19. Clinical management of acute diabetic Charcot foot in Denmark

20. Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trial

21. Duration of off-loading and recurrence rate in Charcot osteo-arthropathy treated with less restrictive regimen with removable walker

22. Efficacy and safety of the PPARγ partial agonist balaglitazone compared with pioglitazone and placebo: a phase III, randomized, parallel-group study in patients with type 2 diabetes on stable insulin therapy

23. Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy

24. Treatment of diabetic ketoacidosis in adults in Denmark: A national survey

25. Diabetic ketoacidosis in Denmark

26. The management of diabetic foot ulcers in Danish hospitals is not optimal

27. The effect of oral loading doses of cholecalciferol on the serum concentration of 25-OH-vitamin-D

28. Abnormal bone collagen morphology and decreased bone strength in growth hormone-deficient rats

29. High Risk of Adrenal Insufficiency in Adults Previously Treated for Idiopathic Childhood Onset Growth Hormone Deficiency

30. Variations in percentage of body fat within different BMI groups in young, middle-aged and old women

31. Comparisons of leptin, incretins and body composition in obese and lean patients with hypopituitarism and healthy individuals

32. Are soft tissue composition of bone and non-bone pixels in spinal bone mineral measurements by DXA similar? Impact of weight loss

33. Are soft tissue composition of bone and non-bone pixels in spinal bone mineral measurements by DXA similar? Impact of weight loss

35. Accuracy of measurements of body composition by dual-energy x-ray absorptiometry in vivo

36. Sympathetic neuropathy in diabetes mellitus patients does not elicit Charcot osteoarthropathy

37. Bone mineral density in diabetes mellitus patients with and without a Charcot foot

38. Changes in calcanean bone mineral occurring spontaneously and during hormone replacement therapy in early post-menopausal women

39. Does abdominal obesity have a similar impact on cardiovascular disease and diabetes? A study of 91,246 ambulant patients in 27 European countries

40. Measurement of body fat in elderly subjects by dual-energy x-ray absorptiometry, bioelectrical impedance, and anthropometry

41. [Charcot's arthropathy]

42. Den diabetiske Charcots fod

43. [Treatment of diabetic ketoacidosis in adults in Denmark--need for national guidelines. Secondary publication]

44. Diabetic ketoacidosis in Denmark Incidence and mortality estimated from public health registries

45. [Drug treatment of obesity]

46. The impact of idiopathic childhood-onset growth hormone deficiency (GHD) on bone mass in subjects without adult GHD

47. Combined dietary and pharmacological weight management in obese hypopituitary patients

48. 40(th) EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 2004

49. Abnormal sympathoadrenal activity, but normal energy expenditure in hypopituitarism

50. [Obesity in Danish hospitals--treatment in the year 2000]

Catalog

Books, media, physical & digital resources